TNF and atherosclerosis: One underlying mechanism is the direct reduction in eNOS caused by inflammatory mediators (e.g., TNF-α, IL-6, and CRP), which are usually elevated under inflammatory conditions.139 Consequently, the proinflammatory matrix and cellular modifications lead to the progression of hypertension and atherosclerosis.14